| Bioactivity | Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC50 of 2.8 nM extracted from patent WO2017210471A1, compound 41[1]. |
| Target | IC50: 2.8 nM (Glucocorticoid receptor) |
| Invitro | Glucocorticoid receptor agonist immunoconjugates are useful for treating autoimmune diseases such as, but not limited to, rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, pediatric Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, Behcets disease, a spondyloarthropathy, or psoriasis[1]. |
| Name | Glucocorticoid receptor agonist-1 |
| CAS | 2166375-82-0 |
| Formula | C35H39NO6 |
| Molar Mass | 569.69 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Michael J. Mcpherson, et al. Glucocorticoid receptor agonist and immunoconjugates thereof. WO2017210471A1. |
Glucocorticoid receptor agonist-1
CAS: 2166375-82-0 F: C35H39NO6 W: 569.69
Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC50 of 2.8 nM extracted from pate
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.